Interpretation of Imaging Chapter 1: Why High-Resolution Computed Tomography (HRCT) Matters
Transcript
Hello, and welcome back to the Interstitial Lung Disease Explainer Video Series. I am Dr Joseph Mammarappallil, a cardiothoracic radiologist at The Duke Medical Center. This series focuses on interpreting high-resolution computed tomography, or HRCT, specifically in diagnosing and characterizing progression in interstitial lung diseases, or ILDs. In this video, you will learn how to recognize key imaging patterns, understand their clinical implications, and integrate radiology findings into multidisciplinary care.
HRCT is the gold standard imaging tool for ILD assessment. With its thin-section images and high spatial resolution, HRCT offers a more precise characterization of architectural changes in ILD. These features cannot be visualized on plain radiographs.
For rheumatologists managing patients with systemic autoimmune rheumatic diseases, or SARDs, the 2023 ACR and CHEST guidelines conditionally recommend HRCT for both screening those at risk and monitoring for disease progression. HRCT is a fundamental diagnostic tool for evaluating the natural history of these diseases, supporting early diagnosis, assessing severity, stratifying prognosis, tracking progression, and promptly identifying short- and long-term complications.
By revealing distinct imaging patterns—such as ground-glass opacities, reticulations, honeycombing, or traction bronchiectasis—HRCT allows for the characterization and distribution of these features, offering the pattern recognition needed to assess fibrosis and monitor its progression over time.
It is, however, important to remember that HRCT must be interpreted in conjunction with clinical findings and serologic and pathologic data. It is best used during multidisciplinary discussions to establish a clinical diagnosis.
The key is making sense of complex HRCT images. By integrating imaging with the patient’s symptoms, lab results, and clinical profile, structured HRCT interpretation turns scan patterns into clear, actionable endpoints that guide patient care.
The key takeaway is that HRCT brings clarity to the clinical picture of ILD. With the support of multidisciplinary colleagues, even complex scans become manageable. This structured approach not only guides diagnosis and monitoring but also creates a clear clinical story that supports ongoing management decisions.
Glossary
ACR – American College of Rheumatology
ATS – American Thoracic Society
CHEST – American College of Chest Physicians
CTD-ILD – Connective Tissue Disease–Related Interstitial Lung Disease
DLCO – Diffusing Capacity of the Lung for Carbon Monoxide
ERS – European Respiratory Society
FVC – Forced Vital Capacity
GGO – Ground-Glass Opacity
HRCT – High-Resolution Computed Tomography
ILD – Interstitial Lung Disease
IPF – Idiopathic Pulmonary Fibrosis
JRS – Japanese Respiratory Society
LIP – Lymphocytic Interstitial Pneumonia
MDD – Multidisciplinary Discussion
NSIP – Nonspecific Interstitial Pneumonia
OP – Organizing Pneumonia
PFTs – Pulmonary Function Tests
SARDs – Systemic Autoimmune Rheumatic Diseases
UIP – Usual Interstitial Pneumonia
References
Baharuddin H, Hanafiah M, Aflah SSS, Zim MAM, Ch'Ng SS. Asymptomatic lymphocytic interstitial pneumonia with extensive HRCT changes preceding Sjogren’s syndrome. Case Rep Pulmonol. 2021;2021:6693031. doi:10.1155/2021/6693031
Brixey AG, Oh AS, Alsamarraie A, Chung JH. Pictorial review of fibrotic interstitial lung disease on high-resolution CT scan and updated classification. Chest. 2024;165(4):908-923. doi:10.1016/j.chest.2023.11.037
Drimus JC, Duma RC, Trăilă D, Mogoșan CD, Manolescu DL, Fira-Mladinescu O. High-resolution CT findings in interstitial lung disease associated with connective tissue diseases: differentiating patterns for clinical practice-a systematic review with meta-analysis. J Clin Med. 2025;14(17):6164. doi:10.3390/jcm14176164
Farkas J. Thoracic radiology: ground-glass opacification (GGO). EMCrit Project Internet Book of Critical Care (IBCC). September 8, 2023. Accessed December 4, 2025. https://emcrit.org/ibcc/ggo/
Gagliardi M, Berg DV, Heylen CE, et al. Real-life prevalence of progressive fibrosing interstitial lung diseases. Sci Rep. 2021;11(1):23988. doi:10.1038/s41598-021-03481-8
Guiot J, Miedema J, Cordeiro A, et al. Practical guidance for the early recognition and follow-up of patients with connective tissue disease-related interstitial lung disease. Autoimmun Rev. 2024;23(6):103582. doi:10.1016/j.autrev.2024.103582
Johnson SR, Bernstein EJ, Bolster MB, et al. 2023 American College of Rheumatology (ACR)/American College of Chest Physicians (CHEST) guideline for the screening and monitoring of interstitial lung disease in people with systemic autoimmune rheumatic diseases. Arthritis Rheumatol. 2024;76(8):1201-1213. doi:10.1002/art.42860
Kligerman SJ, Groshong S, Brown KK, Lynch DA. Nonspecific interstitial pneumonia: radiologic, clinical, and pathologic considerations. Radiographics. 2009;29(1):73-87. doi:10.1148/rg.291085096
Lederer C, Storman M, Tarnoki AD, Tarnoki DL, Margaritopoulos GA, Prosch H. Imaging in the diagnosis and management of fibrosing interstitial lung diseases. Breathe (Sheff). 2024;20(1):240006. doi:10.1183/20734735.0006-2024
Louza GF, Nobre LF, Mançano AD, et al. Lymphocytic interstitial pneumonia: computed tomography findings in 36 patients. Radiol Bras. 2020;53(5):287-292. doi:10.1590/0100-3984.2019.0107
Mehrjardi MZ, Kahkouee S, Pourabdollah M. Radio-pathological correlation of organizing pneumonia (OP): a pictorial review. Br J Radiol. 2017;90(1071):20160723. doi:10.1259/bjr.20160723
Raghu G, Remy-Jardin M, Myers JL, et al; American Thoracic Society, European Respiratory Society, Japanese Respiratory Society, and Latin American Thoracic Society. Diagnosis of idiopathic pulmonary fibrosis. An official ATS/ERS/JRS/ALAT clinical practice guideline. Am J Respir Crit Care Med. 2018;198(5):e44-e68. doi:10.1164/rccm.201807-1255ST
Rodriguez K, Ashby CL, Varela VR, Sharma A. High-resolution computed tomography of fibrotic interstitial lung disease. Semin Respir Crit Care Med. 2022;43(6):764-779. doi:10.1055/s-0042-1755563
Sahn SA. The diagnosis of IPF. Published September 19, 2014. Accessed October 6, 2025. https://www.slideserve.com/xenia/the-diagnosis-of-ipf
Sverzellati N. Highlights of HRCT imaging in IPF. Respir Res. 2013;14 Suppl 1(Suppl 1):S3. doi:10.1186/1465-9921-14-S1-S3
SC-US-81300
Copyright © 2026 Boehringer Ingelheim Pharmaceuticals, Inc.
All Rights Reserved.



